Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 661680 of 20,252 grants

Active NON-SBIR/STTR RPGS
Building a Cancer Epidemiology Cohort to Investigate Factors Associated with Higher Risk of Colorectal Cancer among Alaska Native People
NATIONAL CANCER INSTITUTE Alaska Native Tribal Health Consortium United States 2024 – 2029

PROJECT SUMMARY/ABSTRACT Alaska Native (AN) people have the highest recorded rate of colorectal cancer (CRC) in the world with twofold higher incidence and mortality than US whites...

$4.48M
USD
Active NON-SBIR/STTR RPGS
Structural surfaceomics to probe conformation-selective immunotherapy targets
NATIONAL CANCER INSTITUTE University of California, San Francisco United States 2024 – 2029

PROJECT SUMMARY/ABSTRACT The Problem: Cellular immunotherapies targeting surface proteins are one the most exciting new modalities in cancer. However, most tumors lack surface targ...

$5.5M
USD
Completed OTHER RESEARCH-RELATED
Protein Phosphorylation in Health and Disease
NATIONAL CANCER INSTITUTE Federation of Amer Soc for Exper Biology United States 2024 – 2025

Program Director/Principal Investigator (Last, First, Middle): Tagliabracci, V.S./Yaffe, M. Protein phosphorylation plays a vital role in cellular communication, regulating cellula...

$100K
USD
Active NON-SBIR/STTR RPGS
Microphysiological platform for analyzing multiple myeloma's tumor microenvironment, enabling immunotherapy assessment and drug screening.
NATIONAL CANCER INSTITUTE Northeastern University United States 2024 – 2027

ABSTRACT The tumor microenvironment (TME) plays a critical role in hematologic malignancies, especially in multiple myeloma (MM). Each cellular and non-cellular component of the TM...

$4.27M
USD
Active NON-SBIR/STTR RPGS
Nano-CRISPR extracellular vesicle sensing system for longitudinal tumor monitoring
NATIONAL CANCER INSTITUTE Massachusetts General Hospital United States 2024 – 2027

Detection of reliable biomarkers that represent treatment response and drug resistance remains a major clinical challenge for ovarian cancer. Extracellular vesicles (EVs) represent...

$4.16M
USD
Completed SBIR-STTR RPGS
Engineering in vivo half-life extension of a novel mammalian asparaginase to increase feasibility of pan-cancer therapy
NATIONAL CANCER INSTITUTE Enzyme By Design, Inc United States 2024 – 2025

Project Summary: The goal of this proposal is to extensively broaden the clinical applications of the unique anti-cancer biologic drug L-asparaginase (ASNase) by developing a longe...

$4M
USD
Active NON-SBIR/STTR RPGS
Spatial protein-protein interaction networks in situ by multiplexed proximity ligation
NATIONAL CANCER INSTITUTE Georgia Institute of Technology United States 2024 – 2027

Patients with non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) gene mutations have been successfully treated with EGFR tyrosine kinase inhibitors (EG...

$3.74M
USD
Active NON-SBIR/STTR RPGS
A platform for multi-modal single nucleus spatial genomics for molecular tumor analysis
NATIONAL CANCER INSTITUTE Broad Institute, Inc United States 2024 – 2027

Project Summary Tumors reside within a complex multicellular ecosystem comprised of malignant and non- malignant cells, where interacting cells and molecules are organized in space...

$4.18M
USD
Active NON-SBIR/STTR RPGS
Development of A Directed Evolution Platform for RNA Methyltransferases.
NATIONAL CANCER INSTITUTE Boston College United States 2024 – 2027

PROJECT SUMMARY N6-methyladenosine (m6A) is one of the most abundant chemical modifications in human messenger RNA (mRNA). m6A in mRNA is dynamically regulated by the effector prot...

$2.17M
USD
Active SBIR-STTR RPGS
Targeting the DNA Damage Response sensor Replication Protein A for first inclass cancer therapy
NATIONAL CANCER INSTITUTE Nerx Biosciences, Inc United States 2024 – 2026

Abstract The DNA Damage Response (DDR) is an integrated network of DNA repair and cell signaling pathways that are critical towards maintaining genomic stability. Targeting the DDR...

$10.79M
USD
Completed SBIR-STTR RPGS
The Development of Radiolabeled PSMA Agent with Low Salivary Gland Uptake
NATIONAL CANCER INSTITUTE Tripill Biotechnology, Corp United States 2024 – 2025

Project Abstract Widely overexpressed in prostate cancer tissues, Prostate Specific Membrane Antigen (PSMA) has become an attractive target for both imaging and radionuclide-based...

$4M
USD
Completed SBIR-STTR RPGS
Highly stable mini-circRNA vaccine with maximally activated and long-lasting T cells for HPV-related cancer combination immunotherapy
NATIONAL CANCER INSTITUTE Ampedrna Biosciences Llc United States 2024 – 2025

Human papillomavirus (HPV) is responsible for a large proportion of global cancer cases, including head and neck, cervical and anal cancers, among others. HPV-related cancers are c...

$3.99M
USD
Active NON-SBIR/STTR RPGS
Develop and validate demineralized bone paper-based human bone metabolic and senolytic assays
NATIONAL CANCER INSTITUTE University of Massachusetts Amherst United States 2024 – 2027

Project Summary Bone metastasis is a major cause of morbidity and mortality in cancer survivors. It is closely linked to advanced skeletal aging, which is driven by the accumulatio...

$3.94M
USD
Active SBIR-STTR RPGS
A Phase 1 Study of Patient-Derived Multi-Tumor-Associated Antigen Specific T Cells (MT-601) Administered to Patients with Relapsed Non-Hodgkin Lymphoma
NATIONAL CANCER INSTITUTE Marker Therapeutics, Inc United States 2024 – 2027

ABSTRACT This application presents MT-601, a novel multi-tumor associated antigen (mTAA)-specific T cell product for the treatment of Non-Hodgkin’s Lymphoma (NHL). NHL is the most...

$6.65M
USD
Active NON-SBIR/STTR RPGS
Virginia Advancing Cancer Control Equity Research Through Transformative Solutions (VA-ACCERT) Center
NATIONAL CANCER INSTITUTE Virginia Commonwealth University United States 2024 – 2029

Overall: Project Summary The Virginia Advancing Cancer Control Equity Research Through Transformative Solutions (VA-ACCERT) Center is an academic-public partnership between an inte...

$18.95M
USD
Active NON-SBIR/STTR RPGS
The Virginia Advancing Cancer Control Equity Research Through Transformative Solutions (VA-ACCERT) Center
NATIONAL CANCER INSTITUTE Virginia Commonwealth University United States 2024 – 2029

ADMINISTRATIVE CORE: PROJECT SUMMARY The Administrative Core for the Virginia Advancing Cancer Control Equity Research Through Transformative Solutions (VA-ACCERT) Center will prov...

Active NON-SBIR/STTR RPGS
The Virginia Advancing Cancer Control Equity Research Through Transformative Solutions (ACCERT) Center
NATIONAL CANCER INSTITUTE Virginia Commonwealth University United States 2024 – 2029

RESEARCH METHODS, MEASURES, AND DATA MANAGEMENT (RMMDM) CORE: PROJECT SUMMARY Evaluations of interventions that target the numerous social drivers of health (SDOH) factors experien...

Active NON-SBIR/STTR RPGS
The Virginia Advancing Cancer Control Equity Research Through Transformative Solutions (ACCERT) Center
NATIONAL CANCER INSTITUTE Virginia Commonwealth University United States 2024 – 2029

SOCIAL DRIVERS OF HEALTH (SDOH) RESEARCH PROJECT: PROJECT SUMMARY In the US, individuals and families living in poverty are placed at increased risk for cancer. Living in an under-...

Active NON-SBIR/STTR RPGS
The Virginia Advancing Cancer Control Equity Research Through Transformative Solutions (VA-ACCERT) Center
NATIONAL CANCER INSTITUTE Virginia Commonwealth University United States 2024 – 2029

COMMUNITY RESPONSIVE RESEARCH PROJECTS: PROJECT SUMMARY The Virginia Advancing Cancer Control Equity Research Through Transformative Solutions (VA-ACCERT) Center will support four...

Active SBIR-STTR RPGS
A PROGNOSTIC ASSAY FOR METASTATIC CLEAR CELL RENAL CELL CARCINOMA
NATIONAL CANCER INSTITUTE Lagrange Scientific, Llc United States 2024 – 2027

ABSTRACT An estimated 79,000 Americans were diagnosed with renal carcinoma in 2022 and approximately 13,920 died, primarily as a result of metastasis. First line treatment involves...

$9.28M
USD